Publikationsserver
Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation
Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...
保存先:
| 第一著者: | |
|---|---|
| その他の著者: | |
| フォーマット: | Dissertation |
| 言語: | 英語 |
| 出版事項: |
Philipps-Universität Marburg
2018
|
| 主題: | |
| オンライン･アクセス: | PDFフルテキスト |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
No citations were found for this record.